40

Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 2: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 3: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 4: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 5: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 6: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 7: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 8: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 9: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 10: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 11: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 12: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 13: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 14: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 15: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 16: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

1

ANDA 40-745

CYCLOPHOSPHAMIDE FOR INJECTION USP, 500 MG/VIAL, 1.0 G/VIAL, AND 2.0 G/VIAL

BAXTER HEALTHCARE CORPORATION

Joseph R. Wetzel Office of Generic Drugs Division of Chemistry I

Page 17: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 18: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

Chemistry Review Data Sheet

1. ANDA # 40-745 2. REVIEW #: 2 3. REVIEW DATE: 30-JUN-2007 4. REVIEWER: Joseph R. Wetzel 5. PREVIOUS DOCUMENTS: None

6. SUBMISSION(S) BEING REVIEWED:

Submission(s) Reviewed Document Date Original ANDA 31-JAN-2006 Acceptable for filing 01-FEB-2006 Amendment 09-FEB-2007 Amendment 04-JUN-2007

7. NAME & ADDRESS OF APPLICANT: . Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane

Cherry Hill, NJ 08003 Representative: Sandra P. Bobila Telephone: 856-489-2197 8. DRUG PRODUCT NAME/CODE/TYPE:

a) Proprietary Name N/A b) Non-Proprietary Name (USAN) CYCLOPHOSPHAMIDE FOR INJECTION, USP

9. LEGAL BASIS FOR SUBMISSION: Ref Listed Drug: CYTOXAN Firm: BRISTOL-MYERS SQUIBB NDA#: 12-142

10. PHARMACOL. CATEGORY: CYTOXIC ALKYLATING AGENT

Page 19: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 20: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 21: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 22: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 23: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 24: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 25: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 26: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

23

36. Chemistry Comments to be Provided to the Applicant ANDA:40-745 APPLICANT: Baxter Healthcare Corporation

DRUG PRODUCT: Cyclophosphamide for Injection USP, 500 mg/vial, 1 g/vial, and 2 g/vial

The deficiencies presented below represent Minor deficiencies.

A. Deficiencies:

1. Please use the appropriate significant figures in the drug substance and drug product release specifications. 2.

3.

4. 5.

6. Please submit updated stability data sheets with all the above revisions.

Sincerely yours, Rashmikant M. Patel, Ph.D. Director Division of Chemistry I Office of Generic Drugs Center for Drug Evaluation and Research

(b) (4)

Page 27: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

24

cc: ANDA 40-745 DIV FILE Field Copy Endorsements :

HFD-625 /Joseph R. Wetzel, Review Chemist /06/30/07 HFD-625/ J. Fan, Team Leader/06/30/07

HFD-617/R. Adigun, Project Manager/06/30/07 F/T: \\cdsnas\ogds11\FIRMSAM\BAXTER\LTRS&REV\40745 REV2 jrw.doc Minor

Page 28: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

---------------------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signed electronically andthis page is the manifestation of the electronic signature.--------------------------------------------------------------------------------------------------------------------- /s/---------------------Joseph Wetzel8/8/2007 10:11:00 PMCHEMIST

Rosalyn Adigun8/27/2007 03:00:28 PMCSO

James Fan9/4/2007 05:26:39 PMCHEMIST

Page 29: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

1

ANDA 40-745

CYCLOPHOSPHAMIDE FOR INJECTION USP, 500 MG/VIAL, 1.0 G/VIAL, AND 2.0 G/VIAL

BAXTER HEALTHCARE CORPORATION

Joseph R. Wetzel Office of Generic Drugs Division of Chemistry I

Page 30: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 31: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

Chemistry Review Data Sheet

1. ANDA # 40-745 2. REVIEW #: 3 3. REVIEW DATE:22-JAN-2008 4. REVIEWER: Joseph R. Wetzel 5. PREVIOUS DOCUMENTS:

Original ANDA 31-JAN-2006 Acceptable for filing 01-FEB-2006 Amendment 09-FEB-2007 Amendment 04-JUN-2007

6. SUBMISSION(S) BEING REVIEWED:

Submission(s) Reviewed Document Date Amendment 11-OCT-2007

7. NAME & ADDRESS OF APPLICANT: Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane

Cherry Hill, NJ 08003 Representative: Sandra P. Bobila Telephone: 856-489-2197 8. DRUG PRODUCT NAME/CODE/TYPE:

a) Proprietary Name N/A b) Non-Proprietary Name (USAN) CYCLOPHOSPHAMIDE FOR INJECTION, USP

9. LEGAL BASIS FOR SUBMISSION: Ref Listed Drug: CYTOXAN Firm: BRISTOL-MYERS SQUIBB NDA#: 12-142

Page 32: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 33: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 34: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 35: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 36: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 37: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 38: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra
Page 39: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

20

cc: ANDA 40-745 DIV FILE Field Copy Endorsements :

HFD-625 /Joseph R. Wetzel, Review Chemist /01/22/08 HFD-625/ J. Fan, Team Leader/01/22/08

HFD-617/R. Adigun, Project Manager/01/22/08 F/T: \\Cdsnas1\OGDS11\FIRMSAM\BAXTER\LTRS&REV\40745 REV3 jrw.doc

Page 40: Food and Drug Administration · 2012. 3. 26. · Name: Baxter Healthcare Corporation Anesthesia & Critical Care Address: 2 Esterbrook Lane Cherry Hill, NJ 08003 Representative: Sandra

---------------------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signed electronically andthis page is the manifestation of the electronic signature.--------------------------------------------------------------------------------------------------------------------- /s/---------------------Joseph Wetzel5/22/2008 07:40:09 PMCHEMIST

Rosalyn Adigun5/27/2008 09:25:56 AMCSO

James Fan5/28/2008 09:22:19 AMCHEMIST